Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

A Gram A Day Keeps The Doctor Away

By Dr. Frank D’Ambrosio | March 9, 2018

In a recent report by Doctor Francis D’Ambrosio, medical marijuana patients most successfully replaced medication with marijuana for a variety of different conditions, including cancer, epilepsy, depression, anxiety, and post-traumatic stress disorder (PTSD). Medical marijuana is utilized by a wide variety of patients, and 40 different conditions were named. With prescription opioid abuse costing US citizens an estimated $78.5 billion per year, could medical marijuana be the answer not only for patients’ health but for the economy?

The report surveys patients from the Francis D’Ambrosio medical practice, where we find out more about what conditions patients use cannabis for, their preferred ingestion methods, the feeling they seek when using cannabis, and if they have used cannabis to replace or reduce their intake of any other prescription medications. In total 4,276 people were surveyed who live in and around California.

Key findings:
  • Cannabis is most often used to replace/act as an adjunct to opioids and antidepressants.
  • Men and women use cannabis in almost equal amounts—53.7 percent vs. 46.3 percent.
  • For those who answered the question, women tended to prefer using CBD-heavy products and strains and edibles.
  • Most people get their cannabis from a dispensary.
  • Delivery was the next most common access point for cannabis, followed by “Friend.” Home growing is not common.
  • Blue Dream and OG Kush were definitely the most popular strains.
  • Girl Scout Cookies, Grand Daddy Purple (GDP), Gorilla Glue #4, Jack Herer and Sour Diesel were also very popular.
  • Most medical marijuana users tend to be in their 30s. For CBD, however, the median and mean age is 41.8 and 44.0 years-old respectively.
  • Most patients use less than three grams a day.
  • Most patients use cannabis daily.
  • Smoking cannabis was by far the preferred method of ingestion—41.7 percent chose this method. Edibles and vaping were the next most common, with 28.0 percent and 27.9 percent of users preferring this method.
  • Many people appear to use cannabis in order to relieve pain and anxiety, as well as to relax and get to sleep.
  • Indicas are used more frequently across the board and are used to relieve pain, anxiety, depression, relax the muscles, and so on.

Read the full report here.

(Source: Doctor Frank)

 

Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE